GGrantIndex
Sort

30,917 grants matching tumor microenvironment

Targeting Malignant Gliomas with a Novel Inhibitor of the STAT3 Pathway

$245,325
Amy Beth Heimberger · University Of Tx Md Anderson Can Ctr · P50 · FY2014 · CA

Proteolytic regulation of Wnt signaling in breast cancer stem cells

$245,308
Kai Kessenbrock · University Of California-Irvine · R00 · FY2017 · CA

Effect of allergic asthma on CD8+ TRM-mediated protection from infection

$245,200
Shannon K Bromley · Massachusetts General Hospital · R21 · FY2022 · AI

Targeting Malignant Gliomas with a Novel Inhibitor of the STAT3 Pathway

$245,058
Amy Beth Heimberger · University Of Tx Md Anderson Can Ctr · P50 · FY2013 · CA

SYSTEMIC T CELL IMMUNOTHERAPY OF MALIGNANT GLIOMAS

$245,045
Cleveland Clinic Foundation · R01 · FY2001 · CA

Defining and manipulating quiescence associated DNA damage resistance in single cells

$245,000
Jacob Stewart-Ornstein · University Of Pittsburgh At Pittsburgh · R00 · FY2021 · CA

Defining and manipulating quiescence associated DNA damage resistance in single cells

$245,000
Jacob Stewart-Ornstein · University Of Pittsburgh At Pittsburgh · R00 · FY2020 · CA

Overcoming Immunological Tumor Microenvironment Resistance in Ewing Sarcoma

$245,000
Timothy P Cripe · Research Inst Nationwide Children'S Hosp · U54 · FY2022 · CA

Defining and manipulating quiescence associated DNA damage resistance in single cells

$245,000
Jacob Stewart-Ornstein · University Of Pittsburgh At Pittsburgh · R00 · FY2019 · CA

Regulation of Genomic Instability in Early Breast Cancer

$244,893
Thea D Tlsty · University Of California, San Francisco · R01 · FY2013 · CA

Project 2: Characterization of microenvironmental drivers of neoplasia in BE

$244,851
Anil K Rustgi · Columbia University Health Sciences · U54 · FY2017 · CA

Focused Ultrasound and CAR T Cells for Pediatric Brain Malignancies

$244,839
Natasha Diba Sheybani · University Of Virginia · R21 · FY2025 · CA

Targeting CD137L to MC1R-Expressing Melanoma Cells and Tumors.

$244,801
Mark L McLaughlin · Modulation Therapeutics, Inc. · R41 · FY2015 · CA

Core B: Biospecimen Core

$244,765
Ryan C Fields · Washington University · P50 · FY2023 · CA

27-hydroxycholesterol as a link between obesity and breast cancer pathogenesis

$244,752
Erik Russell Nelson · University Of Illinois At Urbana-Champaign · R00 · FY2015 · CA

COLLAGENOLYSIS-DRIVEN MOLECULAR MOTORS IN CELL MIGRATION AND MATRIX REMODELING

$244,750
Gregory I Goldberg · Washington University · R01 · FY2011 · CA

Osteoblasts and their mesenchymal progenitors in myeloma

$244,741
Joshua Epstein · Univ Of Arkansas For Med Scis · R01 · FY2007 · CA

Osteoblasts and their mesenchymal progenitors in myeloma

$244,741
Joshua Epstein · Univ Of Arkansas For Med Scis · R01 · FY2009 · CA

Osteoblasts and their mesenchymal progenitors in myeloma

$244,741
Joshua Epstein · Univ Of Arkansas For Med Scis · R01 · FY2010 · CA

Osteoblasts and their mesenchymal progenitors in myeloma

$244,741
Joshua Epstein · Univ Of Arkansas For Med Scis · R01 · FY2008 · CA

Defining Tumor Microenvironment and Response to Immune Checkpoint Blockade in HIV-related Anogenital Squamous Cell Carcinomas (Immuno/microenvironment)

$244,723
Howard H Bailey · University Of Wisconsin-Madison · P30 · FY2022 · CA

Regulation of Breast Stem Cells by the Microenvironment

$244,695
Max S. Wicha · University Of Michigan At Ann Arbor · R01 · FY2012 · CA

Regulation of Breast Stem Cells by the Microenvironment

$244,695
Max S. Wicha · University Of Michigan At Ann Arbor · R01 · FY2011 · CA

Effect of Tumor Derived TGF B on Dendritic Cell Vaccines

$244,673
University Of Arizona · R01 · FY2004 · CA

Effect of Tumor Derived TGF B on Dendritic Cell Vaccines

$244,673
University Of Arizona · R01 · FY2003 · CA